Gen Plus Gmbh & Cokg Is A German Contract Development And Manufacturing Organizationcdmobased In Munichestablished In 1999 As A Subsidiary Of Ratiopharmit Becameindependent After Being Acquired By Drmarkus Dachtler In 2015 And Later By Theconscio Group In 2022Thecompany Specializes In End To End Drug Developmentoffering Services From Concept To Commercial Manufacturing With A Gmp Certified Laboratory Of Approximately 1 000 Ma Gen Plus Employs Around 15 Professionals Skilled In Galenics And Analyticsthecompany Provides A Rangeof R&D Solutionsincluding Feasibility Studies And Formulation Developmentas Well As Manufacturing Clinical Trial Materials And Validation Batchesgen Plus Is Known For Its Specialized Capabilitiessuch As 2D D Printing For Personalized Medicineand Thedevelopment Of Innovativedosageformsincluding Solidssemi Solidsand Non Sterileliquidsit Serves A Diversecustomer Baseincluding Pharmaceutical Companiesgenerics Manufacturersand Biotech Firmsfocusing On Agileproduction For Early Phaseclinical Trials Whileadhering To Eu Gmp Standards
